A recent study compared the cytokine profile in newly-diagnosed T2D patients at pre- and post-metformin treatment and showed decreased serum IL-17 levels, but no changes in IFN-γ levels (8). The gene discussed is IL17A; the disease is type 2 diabetes mellitus.